ليست عنوان مقالات لاتين Can we improve the reliability of the Constant-Murley score? Cancer risk in hypertensive patients treated with calcium channel blockers

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Can we improve the reliability of the Constant-Murley score?

2

Can we improve the spatial predictions of seabed sediments? A case study of spatial interpolation of mud content across the southwest Australian margin

3

Can we improve trauma mortality in a state with a voluntary trauma system

4

Can we improve upon approval voting?

5

Can We Improve Upon Human Performance in the Electrophysiology Laboratory?

6

Can we increase adherence to treatment recommendations of the consultation psychiatrist working in a general hospital? A systematic review

7

Can we influence health status and semen quality of breeding stallions by feeding a prebiotic feed additive during one breeding season?

8

Can we integrate bioinformatics data on the Internet?

9

Can we interpret the evolution of coastal land use conflicts? Using Artificial Neural Networks to model the effects of alternative development policies

10

Can we justify historical control groups when using animal models?

11

Can We Learn From History and Unite as Emergency Physicians?

12

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 1: Defining the Agenda

13

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 1: Defining the Agenda

14

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 2: Controlling the Agenda

15

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 2: Controlling the Agenda

16

Can we learn more from the data underlying the statistical α–β model with respect to the dynamical behavior of avalanches?

17

Can We Leave Cognition to Cognitive Psychologists? Comments on an Article by George Loewenstein

18

Can we live on the brane in Schwarzschild–anti de Sitter black hole?

19

Can we maintain turf to customers’ satisfaction with less water?

20

CAN WE MANAGE ALLIGATOR WEED BETTER IN AUSTRALIA? LESSONS FROM HERBICIDE TRIALS

21

Can we manage ecosystems in a sustainable way?

22

Can we map swelling clays with remote sensing?

23

Can we measure in semi-inclusive eN or NN scattering?

24

Can we measure ecological sustainability? Landscape pattern as an indicator for naturalness and land use intensity at regional, national and European level

25

Can We Measure How Hot the Plaque Is? Not Yet, But…

26

Can we meet targets for biofuels and renewable energy in transport given the constraints imposed by policy in agriculture and energy?

27

Can We Minimize the Effects of Opioids on the Bowel and Still Achieve Adequate Pain Control?

28

Can we model organismic causes of working memory, efficiency and fluid intelligence? A meta-subjective perspective

29

Can We Modify Late Functional Outcome in Ebstein Anomaly by Altering Surgical Strategy?

30

Can we observe galaxies that recede faster than light ? —A more clear-cut answer

31

Can we observe the quark gluon plasma in cosmic ray showers

32

Can we optimise treatment of thrombosis?

33

Can we overcome automobile dependence? : Physical planning in an age of urban cynicism

34

Can we play Fun Gay? Disjuncture and difference, and the precarious mobilities of millennial queer youth narratives

35

Can we predict biological condition of stream ecosystems? A multi-stressors approach linking three biological indices to physico-chemistry, hydromorphology and land use

36

Can we predict crashes? The case of the Brazilian stock market

37

Can we Predict Fate of Bleeding in Early Pregnancy?

38

Can we predict habitat quality from space? A multi-indicator assessment based on an automated knowledge-driven system

39

Can we predict long-term sequelae after fractures of the clavicle based on initial findings? A prospective study with nine to ten years of follow-up

40

Can We Predict Long-Term Survival After Pulmonary Metastasectomy for Renal Cell Carcinoma?

41

Can We Predict Patients’ Cooperation During Phacoemulsification Surgery Under Topical Anesthesia?

42

Can we predict performance and spatial structure of two-species mixtures using only single species information from monocultures?

43

Can we predict performance and spatial structure of two-species mixtures using only single species information from monocultures?

44

Can we predict successful completion of the common foundation programme at interview?

45

Can we predict temperature-dependent chemical toxicity to marine organisms and set appropriate water quality guidelines for protecting marine ecosystems under different thermal scenarios?

46

Can we predict the duration of respiratory support in transient tachypnea of the newborn?

47

Can we predict the failure point of a loaded composite material? Original Research Article

48

Can we predict the fate of the Universe?

49

Can we predict the future food production? A sensitivity analysis

50

Can We Predict Thromboembolic Events in Low-Risk Patients Undergoing Catheter Ablation of Atrial Fibrillation?: The Hanging CHAD

51

Can we predict uranium bioavailability based on soil parameters? Part 1: Effect of soil parameters on soil solution uranium concentration

52

Can we predict uranium bioavailability based on soil parameters? Part 2: Soil solution uranium concentration is not a good bioavailability index

53

Can we predict which head and neck cancer survivors develop fears of recurrence?

54

Can we predict which patients with implantable cardioverter defibrillators receive appropriate shock therapy? A study of 155 patients

55

Can We Prepare IVF Culture Media Two Days Before Ovum Pick up Without Affecting Embryological Parameters? A Retrospective Case-Matched Study

56

Can we prepare our bodies over the year to cope with Ramadan fasting more easily? Imam Reza’s health and dietary recommendations for different months of the year

57

Can we prevent azole resistance in fungi?

58

Can We Prevent Breast Cancer?

59

Can We Prevent Heart Failure With Exercise?

60

Can we profile sex offenders? A review of sex offender typologies

61

Can We Provide Reperfusion Therapy to All Unselected Patients Admitted With Acute Myocardial Infarction?

62

Can we pull the plug on warfarin in atrial fibrillation?

63

Can we put aside the LNT dilemma by the introduction of the controllable dose?

64

Can we quantify the benefits of DMDs in multiple sclerosis?

65

Can we rationally design molecularly imprinted polymers?

66

Can we rationally design molecularly imprinted polymers? Original Research Article

67

Can we reach consensus between marine ecological models and DEB theory? A look at primary producers

68

Can we really grow new blood vessels?

69

Can we really learn from model pathogens?

70

Can we really measure the internal energy of hot nuclei with a 4π detection array? Original Research Article

71

Can we really measure the relative permeabilities using the micropore membrane method?

72

Can we really predict risk of cancer?

73

Can we reconcile consumer wishes and provider restraints?

74

Can we reconstruct browsing history and how far back? Lessons from Vaccinium parvifolium Smith in Rees

75

Can we recover information from concordant pairs in binary matched pairs?

76

Can We Reduce Salinity Effects by the Application of Humic Acid on Native Turfgrasses in order to Attain Sustainable Landscape?

77

Can We Reduce Secondary Surgical Interventions and Length of Hospitalization in Percutaneous Nephrolithotomy?

78

Can We Reduce Secondary Surgical Interventions and Length of Hospitalization in Percutaneous Nephrolithotomy?

79

Can we reduce the burden of musculoskeletal conditions? The European action towards better musculoskeletal health

80

Can we reduce the caesarean section rate?

81

Can We Re-Imagine Research So It Is Timely, Relevant and Responsive? Comment on “Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research”

82

Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain?

83

Can we reliably predict long-term mortality after exercise testing? An external validation

84

Can We Rely on Frozen Sections of a Rectal Biopsy for One-stage Trans-anal Pull-through Operation in Hirschsprung's Disease?

85

Can we rely on the multiplex ligation-dependent probe amplification method (MLPA) for prenatal diagnosis?

86

Can we Replace Arterial Blood Gas Analysis by Pulse Oximetry in Neonates with Respiratory Distress Syndrome, who are Treated According to INSURE Protocol?

87

Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials?

88

Can we reposition the preferred geological conditions necessary for an infiltration gallery? The development of a synthetic infiltration gallery Original Research Article

89

Can We Resolve Contradictions between Process Dissociation Models?

90

Can we RESOLVE the treatment of sepsis?

91

Can we restore the Colorado River delta?

92

Can we reverse the HIV/AIDS pandemic with an expanded response?

93

Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?

94

Can we simulate regional groundwater flow in a karst system using equivalent porous media models? Case study, Barton Springs Edwards aquifer, USA

95

Can we skill and activate children through primary school physical education lessons? “move it groove it”—a collaborative health promotion intervention

96

Can We Slow Down the Global Increase of Adiposity?

97

Can we solve the mysteries of the National Vietnam Veterans Readjustment Study?

98

Can we stand the heat?

99

Can we start to think about consensus-oriented clinical practices?

100

Can we still beat “buy-and-hold” for individual stocks?

101

Can We STOP AF With Cryoballoon Ablation?

102

Can we stop national immunisation days before global eradication of poliomyelitis?

103

Can we study intelligence using the experimental method

104

Can we study quark matter in the quenched approximation? Original Research Article

105

Can we synthesise a dense bundle of quasi one-dimensional metallic wires?

106

Can we synthesise a dense bundle of quasi one-dimensional metallic wires?

107

Can we talk? How the cognitive neuroscience of attention emerged from neurobiology and psychology, 1980–2005

108

Can We Talk?: Importance of Random-Digit-Dial Surveys for Injury Prevention Research Review Article

109

Can We Target Smoking Groups More Effectively? A Study of Male and Female Heavy Smokers

110

Can We Tell How a Community Was Constructed? A Comparison of Five Evenness Indices for Their Ability to Identify Theoretical Models of Community Construction

111

Can We Treat Cognitive Deficits in Patients with Epilepsy?

112

Can we treat coronary artery disease with antibiotics?

113

Can We Trust a Compact Bacteriological Screening Test to Identify the Common Vaginal Pathogens?

114

Can we trust elemental abundances derived in late-type giants with the classical 1D stellar atmosphere models

115

Can We Trust Information?

116

Can we trust module-respect heuristics?

117

Can we trust module-respect heuristics?

118

Can we trust odor databases? Example of t- and n-butyl acetate

119

Can we trust PRA?

120

Can we trust PRA?

121

Can we trust the web?

122

Can we understand structural and tectonic processes and their products without appeal to a complete mechanics?

123

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

124

Can we use area per surfactant as a quantitative test model of specific ion effects?

125

Can we use biomass produced from phytoremediation?

126

Can we use complex-valued fractional Brownian motion to derive a fractal space-time theory in micro-physics

127

Can we use disease to control biological invasion?—A theoretical research

128

Can we use disease to control biological invasion?—A theoretical research

129

Can we use erythrocytes for the study of the activity of the ubiquitous Na+/H+ exchanger (NHE-1) in essential hypertension?

130

Can we use fixed ambient air monitors to estimate population long-term exposure to air pollutants? The case of spatial variability in the Genotox ER study

131

Can We Use Heart Rate Recovery Information Generated by Supine Ergometry Exercise?

132

Can We Use Home Sleep Testing for the Evaluation of Sleep Apnea in Obese Pregnant Women?

133

Can we use in vitro fertilization tests to predict semen fertility?

134

Can we use indoor fungi as bioindicators of indoor air quality? Historical perspectives and open questions Review Article

135

Can We Use Placental Growth Factor-Based Tests to Assess Women With Suspected Pre-eclampsia?

136

Can we use serum gamma-glutamyl transferase levels to predict early mortality in stroke?

137

Can wealthy traders claim monopolies in common English words under the UK trade marks act 1994? British Sugar plc v. Robertson & Sons

138

Can Web 2.0 Enhance Community Participation in an Institutional Repository? The Case of PocketKnowledge at Teachers College, Columbia University Original Research Article

139

Can Weblogs and Microblogs Change Traditional Scientific Writing?

140

Can weblogs cause the emergence of social intelligence?: causal model of intention to continue publishing weblog in Japan

141

Can weighing lysimeter ET represent surrounding field ET well enough to test flux station measurements of daily and sub-daily ET? ☆

142

Can Weight Gain Predict the Outcome of Childhood Leukemia?

143

Can wetlands maintained for human use also help conserve biodiversity? Landscape-scale patterns of bird use of wetlands in an agricultural landscape in north India

144

Can white blood cell count be used as a predictor of atrial fibrillation following cardiac surgery? A short literature review

145

Can Wideband Absorbance Be Used in the Detection of Ossicular Chain Defects?

146

Can willingness to pay capture the value of altruism? An exploration of Sen’s notion of commitment

147

Can women in less-developed countries use a simplified medical abortion regimen?

148

Can Women Travel to The Policy-Making Level in Bangladesh? Rural Women’s Political Representation, Participation and Empowerment in the Context of Microfinance

149

Can women without visible pubococcygeal muscle in MR images still increase urethral closure pressures?

150

Can womenʹs autonomy impede male involvement in pregnancy health in Katmandu, Nepal?

151

Can wood ants distinguish between good and bad food patches on the forest floor?

152

Can wood quality justify local preferences for firewood in an area of caatinga (dryland) vegetation?

153

Can wooden poles be used to reconnect habitat for a gliding mammal?

154

Can Working Memory Be Trained through Learning an Additional Language? the effects of TPR versus PPP

155

Can world real interest rates explain business cycles in a small open economy?

156

Can worriers be winners? The association between worrying and job performance

157

Can Wrist Blood Pressure Oscillometer Be Used for Triage in an Adult Emergency Department?

158

Can yeast systems biology contribute to the understanding of human disease? Original Research Article

159

Can Yesterday’s Demand-Side Management Lessons Become Tomorrow’s Market Solutions?

160

Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

161

Can Yoga Be Considered as an Effective Supportive Psychological Intervention with an Impact on the Quality of Life for Breast Cancer Survivors?

162

Can You Adhere Me Now? Good

163

Can You Answer a Question for Me? Processing Indirect Speech Acts

164

Can you bank on GenBank?

165

Can you believe my eyes? The importance of interobserver reliability statistics in observations of animal behaviour

166

Can You Buy a Business Relationship?: On The Importance of Customer and Supplier Relationships in Acquisitions

167

Can you dig it? Use of excavation, a risky foraging tactic, by dugongs is sensitive to predation danger

168

Can you guess the game you are playing?

169

Can you hear the dinner bell? Response of cyprinid fishes to environmental acoustic cues

170

Can you judge a book by its cover? Evidence of self–stranger agreement on personality at zero acquaintance

171

Can you judge a book by its cover? Evidence of self–stranger agreement on personality at zero acquaintance

172

Can you move one eye only?

173

Can you pay people to be healthy?

174

Can You Predict What Happens When EuroSCORE Weds Biomarker?

175

Can you recommend a good book on indexing? Collected reviews on the organization of information : by Bella Hass Weinberg, with a Foreword by Linda K. Fetters and an Index by Susan Klement. Medford, NJ: American Society of Indexers/Information Today, 1998.

176

Can you recommend a good book on indexing?: A Response to the review

177

Can you see the writing on my wall?

178

Can you teach old dogs new tricks? On complementarity of human capital and incentives

179

Can you tickle yourself if you swap bodies with someone else?

180

Can you Trust a Single Data Source Exploratory Software Engineering Case Study?

181

Can younger students succeed where older students fail? An examination of third gradersʹ solutions of a division-with-remainder (DWR) problem

182

Can your institution’s name influence constituent response? An initial assessment of consumer response to college names

183

Can YouTube enhance student nurse learning?

184

Can Zerhouni create a bold, risk-taking NIH?

185

Can Zeta sperm selection method, recover sperm with higher DNA integrity compare to density gradient centrifugation?

186

Can Zinc Be an Option for Prevention of Corona Virus Disease 2019?

187

Can β-blocker therapy be withdrawn from patients with dilated cardiomyopathy?, ,

188

Can γ-radiometrics predict soil textural data and stoniness in different parent materials? A comparison of two machine-learning methods

189

Can δ13C abundance, water-soluble carbon, and light fraction carbon be potential indicators of soil organic carbon dynamics in Zoigê wetland?

190

CAN/[nbp]FeCl4 as a Reusable Catalytic System for Direct Conversion of Trimethylsilyl Ethers to Their Acetates Under Microwave Irradiation

191

Can’t Catch a Breath

192

Can’t see the wood for the trees, can’t see the trees for the numbers? Accounting education, sustainability and the Public Interest

193

Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals

194

195

Canada – Titanium Corp Inc – TiO2 feedstock from tar sand tailings

196

Canada & US: Clariant – masterbatch

197

Canada advises against use of phthalates in childrenʹs toys

198

Canada apologises to native people who suffered abuse

199

CANADA AS A NEW PLACE: THE IMMIGRANT’S EXPERIENCE

200

Canada bans Pigment Red 3 for use as cosmetics ingredient

201

Canada delays legislation on cheap drugs

202

Canada draws near to approving Africa drugs deal

203

Canada finally launches national HIV/AIDS strategy

204

Canada gets fund for health services research

205

Canada gets tough with reproductive technologies

206

Canada hits back at tobacco companies

207

Canada increases breast screening and research

208

Canada introduces “evidence-based” guidelines for breast-cancer care

209

Canada launches breast-cancer strategy

210

Canada lifts ban on blood donors with Creutzfeldt-Jacob disease

211

Canada makes vaccine biotech investment

212

Canada may ban Disperse Blue 19, PDDAM & Pigment Red 251

213

Canada moves to protect babies from chemical

214

Canada moves to stem health-research “brain drain”

215

Canada moves towards “whistle-blowing” law

216

Canada needs better drug reporting, says inquest

217

Canada outlines 10-year research strategy that will “take on the world”

218

Canada plans mental-health outreach

219

Canada post delivers energy conservation

220

Canada proposes strict tobacco controls

221

Canada puts Health Act up for negotiation

222

Canada reacts to water contamination

223

Canada rules no fetal rights

224

Canada sends out urgent appeal for blood

225

Canada shootings linked with abortion

226

Canada silences scientists that spoke out about BSE

227

Canada starts renewed effort against tobacco-industry advertising

228

Canada still seeking research code of ethics

229

Canada strengthens pandemic plan in wake of SARS

230

Canada Thistle [Cirsium arvense (L) Scop.] Response to Density of Cassida rubiginosa Müller (Coleoptera: Chrysomelidae) and Plant Competition

231

Canada to abolish fee-for-service in primary care?

232

Canada to change patent law to allow export of cheap drugs

233

Canada to define essential medical care

234

Canada to limit artificial reproduction technologies

235

Canada to overhaul blood system

236

Canada unveils plans for new blood authority

237

Canada upholds rights of pregnant women

238

Canada waits for “grandaddy” of health-reform studies

239

Canada, South Korea, Netherlands and Sweden: regulatory implications of the convergence of telecommunications, broadcasting and Internet services

240

Canada: Atlantic – barytes

241

Canada: Black Bull – kaolin

242

Canada: Canadian Wollastonite – wollastonite

243

Canada: Cancarb – carbon black

244

Canada: Clariant — plastics masterbatch

245

Canada: Clariant — plastics masterbatch

246

Canada: Ferrinov – anti-corrosion pigments from furnace flue-dust

247

Canada: Hillsborough/NW Pozzolan – kaolin

248

Canada: Optima – plastics masterbatch

249

Canada: QIT – TiO2 feedstock

250

Canada: Rio Tinto – TiO2 feedstock

251

Canada: Western Oil Sands & Altair – TiO2 feedstock & pigment

252

Canada: Western Oil Sands & Altair – TiO2 feedstock & pigment

253

Canada: What it is, What it can be, R. Martin, J. Milway. Toronto University Press, Toronto, ON (2012)

254

Canada: Whitemud – kaolin for cement

255

Canada: Whitemud – kaolin for cement

256

Canada: Whitemud – kaolin for cement

257

Canada’s constitutional separation of (wind) power

258

Canada’s energy perspectives and policies for sustainable development

259

Canada’s New Mental Disorder Disposition Provisions:: A Case Study of the British Columbia Criminal Code Review Board

260

Canada’s Pioneering Women of Vascular Surgery: A Historical Review

261

Canada’s program on nuclear hydrogen production and the thermochemical Cu–Cl cycle

262

Canada’s voluntary agreement on vehicle greenhouse gas emissions: When the details matte

263

Canadaʹs antismoking initiative goes ahead

264

Canadaʹs antitobacco stance even tougher

265

Canadaʹs Atlantic Coastal Action Program: A community-based approach to collective governance

266

Canadaʹs blood inquiry gains strength

267

Canadaʹs British Columbia attacks tobacco companies

268

Canadaʹs budget causes mixed emotions

269

Canadaʹs cancer costs rise

270

Canadaʹs centres of excellence will stay

271

Canadaʹs doctors post reward for abortionistsʹ killers

272

Canadaʹs doctors want technology investment

273

Canadaʹs doctors win

274

Canadaʹs drug industry put under pressure

275

Canadaʹs drug prices poorly controlled

276

Canadaʹs drug-cost burden on patients increases

277

Canadaʹs health care boosted before elections

278

Canadaʹs health ministry gains new chief

279

Canadaʹs health-care reform side tracked

280

Canadaʹs hepatitis C compensation derailed

281

Canadaʹs Liberals make solemn election vows

282

Canadaʹs Medicare principles defended

283

Canadaʹs Mental Health System

284

Canadaʹs ministers agree health package

285

Canadaʹs MRC and drug industry try to make amends

286

Canadaʹs new minerals and metals policy: Advancing the concept of sustainable development in the minerals and metals industry

287

Canadaʹs new prime minister vows to cut surgery wait lists

288

Canadaʹs new regulatory framework. Convergence, competition and the Information Highway

289

Canadaʹs ocean and maritime security a strategic forecast: A strategic forecast

290

Canadaʹs offer to host the ITER project

291

Canadaʹs pharmacists can sell prescribing data

292

Canadaʹs provinces tackle government for more money for Medicare

293

Canadaʹs Red Cross demands HCV-screening funds

294

Canadaʹs Red Cross on the offensive over its future role

295

Canadaʹs Red Cross sells blood assets

296

Canadaʹs research network virtually ready

297

Canadaʹs style of continuing medical education

298

Canadaʹs Supreme Court limits doctorʹs liability

299

Canadaʹs supreme court rejects broadcasterʹs appeal on doctorsʹ libel verdict

300

Canadaʹs university presidents “ecstatic” over funding for research

301

Canadaʹs unpopular health legislation passed

302

Canada-United States Chicken Trade: A Re-Evaluation

303

Canada-Wide Survey of the Nutritional Composition of Six Retail Pork Cuts

304

Canadian Aboriginal communities and medical service patterns for the management of injured patients: a basis for surveillance

305

Canadian Aboriginal peopleʹs experiences with HIV/AIDS as portrayed in selected English language Aboriginal media (1996–2000)

306

Canadian Aboriginal peopleʹs health and the Kelowna deal

307

Canadian Act may mean greater access to personal medical records

308

Canadian advanced life support capacities and future directions Original Research Article

309

Canadian Agricultural Safety Net Programs and Pressures for Change

310

Canadian agri-environmental indicators related to land quality: integrating census and biophysical data to estimate soil cover, wind erosion and soil salinity

311

Canadian AIDS doctor convicted of physicianassisted suicide

312

Canadian Alzheimer collaboration agreed

313

Canadian aquatic science and environmental legislation under threat

314

Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical Practice

315

Canadian Association of Gastroenterology: Strategic Plan 2016–2020

316

Canadian blood-donation prohibition for UK visitors

317

Canadian Bridge Design Code Provisions for Fiber-Reinforced Structures

318

Canadian budget gives healthcare a boost

319

Canadian ceramic breeder technology: recent results

320

Canadian cigarette packs to list toxins and hazards

321

Canadian collaboration networks: A comparative analysis of the natural sciences, social sciences and the humanities

322

Canadian compulsory community treatment laws: Recent reforms

323

Canadian court reaffirms reproductive rights

324

Canadian court says yes to tobacco advertising

325

Canadian court tells government to relax marijuana law for patients

326

Canadian C-spine Rule versus NEXUS in Screening of Clinically Important Traumatic Cervical Spine Injuries; a systematic review and meta-analysis

327

Canadian CT head rule study for patients with minor head injury: methodology for phase II (validation and economic analysis)

328

Canadian Dietary Fat Substitutions, 1955–93, and Coronary Heart Disease Costs

329

Canadian doctorsʹ leaders take charge of project to reduce medical error

330

Canadian doctorʹs murder charge dropped

331

Canadian doctorsʹ prescribing habits for sale

332

Canadian doctors produce charter of demands

333

Canadian doctors vote for two systems

334

Canadian drive to curb drug expenditure

335

Canadian east coast marine-protected areas: A review

336

Canadian epidemiologists examine elective surgery

337

Canadian evidence on long-run neutrality propositions

338

Canadian Exports of Livestock and Meat to the United States

339

Canadian federal government policy and Canadaʹs electronic information industry

340

Canadian Federal Government requirements and support tools for pollution prevention planning

341

Canadian fetal-rights case decided

342

Canadian finance plan plugs health gaps exposed by SARS

343

Canadian genomics project gets kick start

344

Canadian geomorphology 2000: Introduction

345

Canadian government abandon deal for victims of tainted blood

346

Canadian government addresses chemical pollution

347

Canadian government agencies develop e-mail management policies

348

Canadian government allows more patients to use marijuana

349

Canadian government makes guarantees on Medicare

350

Canadian government survives HCV vote

351

Canadian government urged to improve end-of-life care

352

Canadian government will revisit human-cloning legislation

353

Canadian greenhouse gas emissions: 1990–2000

354

Canadian group calls for more environmental health studies

355

Canadian Headache Society criteria for the diagnosis of acute migraine headache in the ED—do our patients meet these criteria?

356

Canadian Health and Food: The Links between Policy, Consumers, and Industry

357

Canadian health-care spending soars

358

Canadian hopes for low-cost drugs dashed

359

Canadian hospitals call for restrictions on single-use devices

360

Canadian House Dust Study: Population-based concentrations, loads and loading rates of arsenic, cadmium, chromium, copper, nickel, lead, and zinc inside urban homes Original Research Article

361

Canadian hydrogen safety program

362

Canadian hypertension society guidelines for ambulatory blood pressure monitoring

363

Canadian infection-control experts push for health reform

364

Canadian insights: The challenges of an integrated environmental assessment framework

365

Canadian institutes fund new initiatives in health research

366

Canadian Intellectual Property Office: backfile conversion project: 1992–1996

367

Canadian judge allows marijuana as therapy

368

Canadian kimberlites: Geological characteristics relevant to emplacement

369

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

370

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

371

Canadian Medical Association champions private medicine

372

Canadian Medical Associationʹ president guilty of misconduct

373

Canadian men need a healthier lifestyle

374

Canadian mercury inventories: the missing pieces

375

Canadian military malarial prophylaxis under scr utiny

376

Canadian Milling Practice : Edited by B. Damjanovic and J.R. Goode xi + 292 pages 22x 28.7 cm, hard cover, published by Canadian Institute of Mining, Metallurgy, and Petroleum, Montreal 2000. Price $80 ($65 for members, $45 for students) + postage ($10 Ca

377

Canadian MRC encourages private sector partnership

378

Canadian multicenter pilot trial of haploidentical donor transplantation

379

Canadian National Air Pollution Surveillance (NAPS) PM2.5 speciation program: Methodology and PM2.5 chemical composition for the years 2003–2008

380

Canadian National Breast Screening Study

381

Canadian national power quality survey: frequency and duration of voltage sags and surges at industrial sites

382

Canadian naturopathic practitioners: holistic and scientific world views

383

Canadian NOx/VOC Science Assessment: science and policy linkages

384

Canadian Occupational Performance Measure Supported by Talking Mats: An Evaluation of the Clinical Utility

385

Canadian officials criticised over soldiersʹ care

386

Canadian officials watch SARS-like mystery bug

387

Canadian Opinions on Refractive Surgery and Approaches to Presbyopia Correction

388

Canadian panel calls for review of drug-trial confidentiality agreements

389

Canadian Parliament finally agrees human reproduction research act

390

Canadian pastoral: promotional images of British colonization in Lower Canadaʹs Eastern Townships during the 1830s

391

Canadian patent profile: Some explorations in patent statistics Original Research Article

392

Canadian petrochemical plants blamed for gender imbalance

393

Canadian practitionersʹ perception of research work investigating the cost premiums, long-term costs and health and productivity benefits of green buildings

394

Canadian programme reverses high anaemia incidence

395

Canadian prohibition against immigrants with disabilities is challenged

396

Canadian province opens door to two-tier health service

397

Canadian provincial health ministers press for change

398

Canadian R&D abroad management practices

399

Canadian Red Cross fires secretary-general

400

Canadian Red Cross found negligent

401

Canadian regulation of private security in an international perspective

402

Canadian regulatory approach to ensuring the implementation of effective ageing management programs for nuclear power plants

403

Canadian report quantifies cost of medical errors

404

Canadian researchers awarded record damages

405

Canadian researchers respond to CMAJ crisis

406

Canadian respirologistʹs murder trial appeal quashed

407

Canadian retailing strategy: Challenges and change : William A. Crowe and Mark E. Siemonsen Nelson Canada, Scarborough, Ontario: (1996) 444 pp. ISBN 0 17 6055770

408

Canadian scientists urge government to develop antibiotic plan

409

Canadian scientists vindicated over whistleblowing

410

Canadian settlement guarantees world medical isotope supply

411

Canadian soldiers and doctors face torture allegations

412

Canadian space environment program and international living with a star Original Research Article

413

Canadian spending on prescription drugs is increasing

414

Canadian Steinernematid (Nematoda) Isolates and Their Infectivity, under Cold Conditions, to Greater Wax Moth (Galleria mellonella) Larvae

415

Canadian suppliers of mining goods and services: links between Canadian mining companies and selected sectors of the Canadian economy: Minerals and Metals Sector; Natural Resources Canada, 2000, xvi + 58pp., free upon request, ISBN 0-662-84954-7, softcove

416

Canadian tourist information and the UK: plans and perceptions

417

Canadian universities go shopping for research scientists

418

Canadian university publishes new rules to protect scientists

419

Canadian waters provide critical foraging habitat for leatherback sea turtles Original Research Article

420

Canadians allow targeted transfusion

421

Canadians are fighting fit, says government report

422

Canadians finally fill regulatory void with stem-cell bill

423

Canadians in Alabama: a perceptual study of dialect acquisition in adults

424

Canadians inquire into drug licensing

425

Canadians propose overhaul of research-ethics guidelines

426

Canadians still stung by WHOʹs SARS travel advisory

427

Canagliflozin-associated Peripheral Vascular Ischemia: A Case Report

428

Canal blocking strategies for hydrological restoration of degraded tropical peatlands in Central Kalimantan, Indonesia

429

Canal configuration of mandibular first premolars in an Egyptian population

430

Canal Configuration of Mesiobuccal Roots in Permanent Maxillary First Molars in Iranian Population: A Systematic Review

431

Canal of Nuck hernias

432

Canal preparation for prosthetic radial head replacement: rasping versus reaming

433

Canal surfaces in 4-dimensional Euclidean space

434

Canal Transportation and Centering Ability of ProTaper and SafeSider in Preparation of Curved Root Canals: A CBCT Evaluation

435

Canal Transportation and Centering Ability of Reciproc Blue, WaveOne Gold and ProTaper Next in Simulated Curved Canals

436

Canal Transportation and Centering Ability of Twisted File and Reciproc: A Cone-Beam Computed Tomography Assessment

437

Canal Transportation and Centering after Using PathFile and R-Pilot in Mesiobuccal Canals of Maxillary Molars Using Cone-Beam Computed Tomography

438

Canal Transportation and Centring Ability of Reciproc and Reciproc Blue With or Without Use of Glide Path Instruments: A CBCT Study

439

Canal water treatment with rapid sand filtration

440

Canaletto’s paintings open a new window on the relative sea-level rise in Venice

441

Canalicular adenoma of the hard palate: A rare case report

442

Canalicular and Naolacrimal Duct Blockage: An Ocular ide Effect Aociated With the Antineoplatic Drug -1

443

Canalicular bile formation: beyond single transporter functions

444

Canalicular fluid flow induced by bending of a long bone

445

Canalis Sinuosus Damage after Immediate Dental Implant Placement in the Esthetic Zone

446

Canalization as a non-genetic source of adaptiveness during morphogenesis: experimental evidence from analysis of reproductive development in Sorghum bicolor

447

Canalization of development and ecdysteroid timing during the last instar in lubber grasshoppers

448

Canals and Communities. Small-scale Irrigation Systems, Edited by J. Mabry, University of Arizona Press, 1996. ISBN 0816515921, pp. 273

449

Canard phenomenon for an SIS epidemic model with nonlinear incidence

450

Canard solution and its asymptotic approximation in a second-order nonlinear singularly perturbed boundary value problem with a turning point

451

Canard solutions of two-dimensional singularly perturbed systems

452

Canards and mixed-mode oscillations in a forest pest model

453

454

CANARD-WING INTERACTIONS IN SUBSONIC FLOW

455

Canary current upwelling: More or less?

456

Canary in the coalmine: Norwegian attitudes towards climate change and extreme long-haul air travel to Aotearoa/New Zealand

457

Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis

458

Canataxpropellane, a novel taxane with a unique polycyclic carbon skeleton (tricyclotaxane) from the needles of Taxus canadensis

459

Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers

460

Canavan disease: a monogenic trait with complex genomic interaction

461

Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing

462

CaNb2O6 ceramics prepared by a reaction-sintering process

463

c-ANCA as a marker of Wegenerʹs disease

464

c-ANCA as a serological pitfall

465

C-ANCA Positive Vasculitis in a Case of Amyloidosis

466

Cancarb appoints European agents for its Thermax thermal blacks

467

CAN-catalyzed syntheses of 3,4-dihydroquinoxalin-2-amine derivatives based on isocyanides

468

CAN-catalyzed three-component reaction between anilines and alkyl vinyl ethers: stereoselective synthesis of 2-methyl-1,2,3,4-tetrahydroquinolines and studies on their aromatization

469

470

Canceling out both the real and the spectral lines

471

Canceling print serials in favor of electronic: criteria for decision making

472

Cancellable biometerics featuring with tokenised random number

473

Cancellable biometrics and annotations on BioHash

474

Cancellation among finite unary algebras Original Research Article

475

Cancellation and Focus: The Role of Shared and Unique Features in the Choice Process

476

Cancellation Conditions for Finite Two-Dimensional Additive Measurement

477

Cancellation errors in an integral for calculating magnetic field from reduced scalar potential

478

Cancellation in cyclic consecutive systems

479

Cancellation is exponentially powerful for computing the determinant

480

Cancellation of bending-induced birefringence in single-mode fibers: application to Faraday sensors

481

Cancellation of Capacitor Parasitic Parameters for Noise Reduction Application

482

Cancellation of digraphs over the direct product

483

Cancellation of elective oral and maxillofacial operations

484

Cancellation of Elective Surgeries in a Tertiary Care Hospital in North India

485

Cancellation of fine-structure splitting in quantum dots by a magnetic field

486

Cancellation of Harmonic Interference by Baseline Shifting of Wavelet Packet Decomposition Coefficients

487

Cancellation of heat effects in catalytic distillation

488

Cancellation of image crosstalk in time-sequential displays of stereoscopic video

489

Cancellation of Infrared Divergences at Finite Temperature

490

cancellation of land certificate based on the court decision in indonesian legal system

491

CANCELLATION OF MASS-LOADING EFFECTS OF TRANSDUCERS AND EVALUATION OF UNMEASURED FREQUENCY RESPONSE FUNCTIONS

492

Cancellation of operations in Saudi Arabian hospitals: Frequency, reasons and suggestions for improvements

493

Cancellation of polarized impulsive noise using an azimuth-dependent conditional mean estimator

494

Cancellation of projective modules over regular rings with comparability Original Research Article

495

Cancellation of renormalon ambiguities in the heavy quark effective theory Original Research Article

496

Cancellation of second-order intermodulation distortion and enhancement of IIP2 in common-source and common-emitter RF transconductors

497

Cancellation of Series-Loss Resistance in UWB Active Inductors using RC Feedback

498

Cancellation of Simulated Environmental Noise as a Tool for Measuring Vocal Performance During Noise Exposure

499

Cancellation of star light generated by a nearby star–planet system upon detection with a rotationally-shearing interferometer

500

Cancellation of Sudakov logarithms in radiative decays of quarkonia Original Research Article

501

Cancellation of the Heating Piston Effect by Convective Enhancement of a Cooling Piston Effect

502

Cancellation problem of preconditioning method at low Mach numbers

503

Cancellation properties for quotient divisible groups

504

Cancellation properties of products of graphs

505

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

506

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

507

Cancellation provisions in Australiaʹs Commonwealth-managed fisheries

508

Cancellation task in very low educated people

509

Cancellation techniques in underwater scattering of acoustic signals

510

Cancellation Theorems Related to Conjectures of Alperin and Dade

511

Cancellations in ambulatory day surgery: Ten years observational study

512

Cancellations in day-case ENT surgery

513

Cancellations in neutrinoless double beta decay and the neutrino mass matrix Original Research Article

514

Cancellative pairs of families of sets

515

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part I)

516

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part II)

517

Cancellativity properties for t-norms and t-subnorms

518

Cancelled IGF-1 trials bode ill for diabetic patients

519

Cancelling Jüttner distributions for space-like freeze-out

520

Cancelling quadratic divergences without supersymmetry Original Research Article

521

Cancelling vibrations in flexible articulated structures using non-causal inverse dynamics

522

Cancellous and cortical bone mineral density around an elastic press-fi t socket in total hip arthroplasty

523

Cancellous and cortical morselized allograft in revision total hip replacement:: A biomechanical study of implant stability

524

Cancellous bone architecture: Advantages of nonorthogonal trabecular alignment under multidirectional joint loading

525

Cancellous bone biomechanics

526

Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: Separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)

527

Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level

528

Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution

529

Cancellous bone repair using bovine trabecular bone matrix particulates

530

Cancellous impaction and cortical strut allografting for revision shoulder arthroplasty: A case report

531

532

Cancer – Blame it all on viruses! Bladder tumours in cattle and sarcoids in horses may help us understand the relationship between some cancers and viruses

533

Cancer Risk in Pakistan Due to Natural Environmental Pollutants

534

Cancer “challenge” to limited-resource countries

535

Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity

536

Cancer among Farmers: A Meta-Analysis

537

Cancer and a Fatiguing Illness in Northern Nevada—A Causal Hypothesis

538

Cancer and aging: The molecular pathways

539

Cancer and Body Composition: An Association of Global Relevance

540

Cancer and comorbidity in older patients: A descriptive profile

541

Cancer and Complications of Peptic Ulcer in Type 2 Diabetes Mellitus patients at Wasit province, Iraq

542

cancer and covid-19: the synergistic burden on mental health status of patients with cancer

543

Cancer and Emotion; the Scope of Psycho‐Socio‐Oncology

544

Cancer and Emotion; The Scope of Psycho‐Socio‐Oncology: At the Time of Diagnosis

545

Cancer and Emotion; The Scope of Psycho-Socio-Oncology: At the Time of Treatment

546

Cancer and globalization

547

Cancer and HIV infection in Rwanda

548

Cancer and incontinence

549

Cancer and inflammation: A complex relationship

550

Cancer and its Treatment in Main Ancient Books of Islamic Iranian Traditional Medicine (7th to 14th Century AD)

551

Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of Cancer

552

Cancer and male infertility

553

Cancer and mutant DNA in blood plasma

554

Cancer and natural medicine: Textbook of basic science and clinical research: By John Boik, Oregon Medical Press, 1996

555

Cancer and Non-Cancer Risk of Arsenic in Drinking Water: A Case Study

556

Cancer and nonextensive statistics

557

Cancer and ovarian tissue cryopreservation

558

Cancer and psychosocial distress: frequent companions

559

Cancer and self-help: Bridging the troubled Waters of childhood illness : By Mark A. Chesler and Barbara K. Chesney. The University of Wisconsin Press, Madison, WI, 1995. 416 pp

560

Cancer and the human genome: no quick fix

561

Cancer and the meaning of work

562

Cancer and thromboembolic disease: how important is the risk of thrombosis?

563

Cancer and thromboembolic disease: pathogenic mechanisms

564

Cancer and thrombosis revisited

565

Cancer and venous thromboembolism

566

Cancer and Women’s Health

567

Cancer and wood-related occupational exposure in the Amazon region of Brazil

568

Cancer anorexia and cachexia

569

Cancer anorexia: a model for the understanding and treatment of secondary anorexia

570

Cancer anorexia: new pathogenic andtherapeutic insights

571

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

572

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

573

Cancer as a Complex Genetic Trait: Tumor Susceptibility in Humans and Mouse Models

574

Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway

575

Cancer associated with obstetric delivery: results of linkage with the California cancer registry

576

Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients

577

Cancer biology for the clinic and the lab

578

Cancer biomarker and neurotransmitters recognition by molecularly imprinted xero-gels

579

Cancer biomarkers

580

Cancer Biomarkers

581

Cancer biomarkers detection using 3D microstructured protein chip: Implementation of customized multiplex immunoassay

582

Cancer Biomarkers: Closer to Delivering on their Promise

583

Cancer Biopsy in Ancient Persian Medicine: Do or Not to Do!

584

Cancer bio-repository

585

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

586

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

587

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

588

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

589

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive

590

Cancer bronchique non à petites cellules: mise au point en 1998

591

Cancer bronchique : le drainage lymphatique

592

Cancer burden and trends in the asian pacific RIM region

593

Cancer cachexia

594

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation

595

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

596

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

597

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

598

Cancer cachexia: Metabolic alterations and clinical manifestations

599

Cancer Cancer vaccines: a road map for the next decade

600

Cancer care during the natural disasters, the lessons learned from Kermanshah Earthquake in 2017

601

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations

602

Cancer cell detection in tissue sections using AFM

603

Cancer cell dissemination during curative surgery for colorectal liver metastases

604

Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data

605

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

606

Cancer Cell Metabolism: Warburg and Beyond

607

Cancer Cell progression

608

Cancer Cell Separation Using Passive Mechanisms: a Review

609

Cancer cell separator using size-dependent filtration in microfluidic chip

610

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

611

Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

612

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains

613

Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate

614

Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor study

615

Cancer chemoprevention with garlic and its constituents

616

Cancer Chemoprevention. Vol. 2: Strategies for Cancer Chemoprevention.G.J. Kellof, E.T. Hawk and C.C. Sigman, Editors, Humana Press, Totowa (2005).

617

Cancer Chemoprevention. Volume I. Promising Cancer Chemopreventive Agents.G.J. Kelloff, E. T. Hawk and C.C. Sigman, Editors, P. Humana Press, Totowa (2004)

618

Cancer chemoprevention: A radical perspective

619

Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants

620

Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis

621

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

622

Cancer chemopreventive activity of acridone alkaloids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

623

Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens

624

Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.

625

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis

626

Cancer chemopreventive activity of flavanones on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

627

Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis

628

Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants

629

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

630

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

631

Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis

632

Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations

633

Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum

634

Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr

635

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis

636

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

637

Cancer chemopreventive effect of dietary Zataria multiflora essential oils

638

Cancer chemopreventive effect of orally administrated lupane-type triterpenoid on ultraviolet light B induced photocarcinogenesis of hairless mouse

639

Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus activation

640

Cancer chemopreventive effects of constituents of Caesalpinia ferrea and related compounds

641

Cancer chemopreventive effects of oral feeding α-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse

642

Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice

643

Cancer chemopreventive effects of polyunsaturated fatty acids

644

Cancer Chemo-Preventive Effects of Red Propolis: a System Biology Approach

645

Cancer chemopreventive oltipraz generates superoxide anion radical

646

Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations

647

Cancer chemotherapy – ribonucleases to the rescue Review Article

648

Cancer Chemotherapy and Biotherapy

649

Cancer chemotherapy in the older cancer patient

650

Cancer chemotherapy optimization under evolving drug resistance Original Research Article

651

Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

652

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

653

Cancer chemotherapy: A SN-38 (7-Ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug monoTherapy) strategy

654

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

655

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

656

Cancer Classification in Microarray Data using a Hybrid Selective Independent Component Analysis and υ‑Support Vector Machine Algorithm

657

Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble

658

Cancer Control at the Workplace: The Working Well Trial

659

Cancer Control strategy in the world, a review article

660

Cancer control: a reminder of the need for a balanced approach between prevention and treatment

661

Cancer cutané et xéroderma pigmentosum

662

Cancer cutané et xéroderma pigmentosum

663

Cancer de l’endomètre de stade I

664

Cancer de l’estomac : doses et volumes-cibles

665

Cancer de l’estomac. Le point thérapeutique en 2008

666

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

667

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

668

Cancer de la prostate

669

Cancer de la prostate 2010. Innovations thérapeutiques

670

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

671

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

672

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

673

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

674

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

675

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

676

Cancer de la thyroïde après exposition aux rayonnements ionisants

677

Cancer de lʹœsophage : répercussion des thérapeutiques néoadjuvantes sur la morbidité et la mortalité opératoire

678

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

679

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

680

Cancer de prostate localisé. Que dire au patient ?

681

Cancer de prostate : doses et volumes cibles

682

Cancer death epidemics in United States Black males: Evaluating courses, causation, and cures

683

CANCER DEATH RATES AND BACKGROUND RADIATION

684

Cancer detection and mammogram volume of radiologists in a population-based screening programme

685

Cancer detection from textual data using a combination of machine learning approach

686

Cancer Detection Using Aritifical Neural Network and Support Vector Machine: A Comparative Study

687

Cancer Development and Electromagnetic Fields in Near Future

688

Cancer diagnosis by autofluorescence of blood components

689

Cancer Diagnosis Disclosure: What is the Right Thing to Do?

690

Cancer Diagnosis in Endoscopic Images using Discrete Wavelet Transform

691

Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study

692

Cancer Disclosure in Iran: Attitude of Patients and Their Families

693

Cancer disclosure in Japan: Historical comparisons, current practices

694

Cancer distress screening: Needs, models, and methods

695

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

696

Cancer driver mutations in protein kinase genes

697

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

698

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

699

Cancer du cavum au centre tunisien : à propos de 525 cas

700

Cancer du cavum au centre tunisien : à propos de 525 cas

701

Cancer du cavum chez le sujet jeune

702

Cancer du cavum chez le sujet jeune

703

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

704

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

705

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

706

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

707

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

708

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

709

Cancer du cavum dans le centre tunisien : facteurs pronostiques

710

Cancer du cavum dans le centre tunisien : facteurs pronostiques

711

Cancer du cavum du sujet âgé

712

Cancer du cavum du sujet âgé

713

Cancer du cavum et syndromes paranéoplasiques

714

Cancer du cavum et syndromes paranéoplasiques

715

Cancer du col utérin

716

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

717

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

718

Cancer du col utérin stades IB et II opérable : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première suivies d’une radiothérapie

719

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

720

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

721

Cancer du larynx chez le sujet âgé

722

Cancer du larynx chez le sujet âgé

723

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

724

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

725

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

726

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

727

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

728

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

729

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

730

Cancer du rectum avec métastases synchrone

731

Cancer du rectum avec métastases synchrone

732

Cancer du rectum chez le sujet de moins de 40 ans

733

Cancer du rectum chez le sujet de moins de 40 ans

734

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

735

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

736

Cancer du rectum : volumes cibles de la radiothérapie préopératoire

737

738

Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas

739

Cancer du sein chez la femme âgée

740

Cancer du sein chez la femme âgée

741

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

742

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

743

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

744

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

745

Cancer du sein chez la femme jeune au Maroc

746

Cancer du sein chez la personne âgée : place de la radiothérapie ?

747

Cancer du sein chez la personne âgée : place de la radiothérapie ?

748

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

749

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

750

Cancer du sein de la femme de moins de 35 ans

751

Cancer du sein de la femme de moins de 35 ans

752

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

753

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

754

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

755

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

756

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

757

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

758

Cancer du sein localement évolué non inflammatoire traité par association de chimiothérapie et de radiothérapie à dose préopératoire : réactualisation des résultats d’une série de 120 patientes

759

Cancer du sein métastatiques : intérêt du CA 15-3

760

Cancer du sein métastatiques : intérêt du CA 15-3

761

Cancer du sein négligé et localement évolué : quelle réalité ? Réflexion à propos de deux cas sur l’optimisation de la prise en charge multidisciplinaire

762

Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature

763

Cancer du sein traité exclusivement par l’association d’une irradiation externe et d’une curiethérapie exclusive : résultats à long terme

764

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

765

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

766

Cancer du sein. Questions et réponses au quotidien, J Saglier, EC Antoine. Masson, New York (1996), 125

767

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

768

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

769

Cancer education among primary care physicians in an underserved community

770

Cancer epidemiology and trends in Sistan and Baluchestan province, Iran

771

Cancer Epidemiology in Lebanon

772

Cancer Epidemiology in Radiation Oncology: An Institutional Experience From North India During 2016-2022

773

Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention

774

Cancer epigenetics as biomarkers of clinical significance

775

Cancer epigenetics is no Mickey Mouse

776

Cancer epigenetics is no Mickey Mouse

777

Cancer Epigenetics: From Mechanism to Therapy

778

CANCER ESOPHAGUS: AN AUDIT OF CURRENT MANAGEMENT FOR YEMENI PATIENTS

779

Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature

780

Cancer experts square up for European funds

781

Cancer familiarity status in patients with early brest cancer: Our experience

782

Cancer fatalism among african-americans: A review of the literature

783

Cancer Feature Selection and Classification Using a Binary Quantum-Behaved Particle Swarm Optimization and Support Vector Machine

784

Cancer gene may move quickly into skin clinics

785

Cancer gene therapy targeting cellular apoptosis machinery

786

Cancer genes and molecular oncology in the clinic

787

Cancer gene-therapy: clinical trials

788

Cancer Genetics and Cytogenetics

789

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

790

Cancer genetics and genomics of human FOX family genes

791

Cancer Genetics and the Cardiotoxicity of the Therapeutics

792

Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

793

Cancer Genomes Evolve by Pulverizing Single Chromosomes

794

Cancer genomics

795

Cancer Genomics: The Road Ahead

796

Cancer groups meet in Edinburgh

797

cancer has an independent association with death in hospitalized patients with covid-19: a single-center study in iran

798

Cancer hazard identification and qualitative risk assessment

799

Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges

800

Cancer hopes and setbacks

801

Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer

802

Cancer immunoprevention: tracking down persistent tumor antigens

803

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

804

Cancer immunotherapy – broader considerations

805

Cancer Immunotherapy Using Microfluidic Systems

806

Cancer immunotherapy, mathematical modeling and optimal control

807

Cancer immunotherapy: novel strategies and clinical experiences

808

Cancer immunotherapy: simply cell biology?

809

Cancer immunotherapyʹs renaissance

810

Cancer in home care: Unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe

811

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)

812

Cancer in Korean War Navy Technicians: Mortality Survey after 40 Years

813

Cancer in Lebanon: An Epidemiological Review of the American University of Beirut Medical Center Tumor Registry (1983–1994)

814

Cancer in married couples: Higher or lower distress?

815

Cancer in Maysan: Mortality, Pattern, and Demographic Characteristics during the Last 4 Decades

816

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Original Research Article

817

Cancer in patients on renal replacement therapy in Lombardy, Italy

818

Cancer in people with depression or anxiety: record-linkage study

819

Cancer in pregnancy: Gaps, challenges and solutions

820

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

821

Cancer in the mass print media: Fear, uncertainty and the medical model

822

Cancer in the older person

823

Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors Original Research Article

824

Cancer incidence among Danish Seventh-day Adventists and Baptists

825

Cancer incidence among Mormons and non-Mormons in Utah (United States) 1995–1999

826

Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study

827

Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999

828

Cancer Incidence among the Elderly Population in the Northwest of Iran: A Population Based Study

829

Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998

830

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

831

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

832

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

833

Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006

834

Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987–2007

835

Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015

836

Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 – 2010

837

Cancer Incidence around an Oil Refinery as an Example of a Small Area Study Based on Map Coordinates

838

Cancer incidence estimation at a district level without a national registry: A validation study for 24 cancer sites using French health insurance and registry data

839

Cancer incidence in a petrochemical industry area in Sweden Original Research Article

840

Cancer incidence in children conceived with assisted reproduction technology

841

Cancer incidence in Dutch Balkan veterans

842

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population

843

Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

844

Cancer incidence in Jordan, 1996–2005

845

Cancer Incidence in Montana: Rates for American Indians Exceed Those for Whites Original Research Article

846

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

847

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998

848

Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry

849

Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 – 2001

850

Cancer incidence in the USA could double by 2050, report predicts

851

Cancer incidence in women exposed to DES in utero

852

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

853

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

854

Cancer Incidence Rates among Iranian immigrants in Sweden, a Population-Based Retrospective Cohort Study

855

Cancer Incidence, Mortality and Survival in Türkiye as of 2020

856

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

857

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

858

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

859

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

860

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

861

Cancer informatics by prototype networks in mass spectrometry

862

Cancer Information Service-Initiated Outcalls to Promote Screening Mammography among Low-Income and Minority Women: Design and Feasibility Testing, ,

863

Cancer initiation by fumonisin B1 in rat liver – role of cell proliferation

864

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

865

Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon

866

Cancer letters special issue hepatocellular carcinoma featuring the guest editors

867

Cancer Letters special issue inflammation and gastrointestinal and liver cancers featuring the guest editor

868

Cancer Letters. Featuring the guest editors: Wael M. ElShamy and Roy J. Duhé

869

Cancer magnitude, challenges and control in the Eastern Mediterranean Region

870

Cancer marker detection in human serum with a point-of-care low-cost system

871

Cancer metabolism and the dynamics of metastasis

872

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

873

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

874

Cancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis

875

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

876

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)

877

Cancer Modeling and Simulation, L. Preziosi (Ed.). Chapman and Hall/CRC (2003)

878

Cancer Modeling in the Modern Era: Progress and Challenges

879

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

880

Cancer molecules reveal their mechanisms

881

Cancer morbidity in subjects occupationally exposed to high frequency (radiofrequency and microwave) electromagnetic radiation

882

Cancer mortality among agricultural workers from Serrana Region, state of Rio de Janeiro, Brazil

883

Cancer mortality among workers in formaldehyde industries

884

Cancer mortality among workers in the meat department of supermarkets : E. S. Johnson, Occupational and Environmental Medicine, 51(8), 541–547

885

Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland

886

Cancer mortality and offset printing

887

Cancer mortality and prevention in the European Union

888

Cancer mortality around French nuclear sites

889

Cancer mortality in Basrah: a household survey results

890

Cancer nanomedicine: A review on approaches and applications towards targeted drug delivery

891

Cancer nanomedicines targeting tumor extracellular pH

892

Cancer nanomedicines: So many papers and so few drugs!

893

Cancer nanotechnology

894

Cancer nanotechnology

895

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

896

Cancer Nursing: Care in Context: Jessica Corner, Christopher Bailey (Eds.); Blackwell Science, Oxford, 2001, ISBN 0-632-03998-1

897

Cancer Occurrence in Fars Province, Southern Iran

898

Cancer Occurrence in the Elderly: Agreement between Three Major Data Sources

899

Cancer of children in Basrah-Iraq: Person and time characteristics

900

Cancer of Male Urethra: Case Series and Review of Literature

901

Cancer of the breast, fifth edition.: William L. Donegan and John S. Spratt publisher: Saunders, Philadelphia, pages: 1,025. price: $179.00

902

Cancer of the breast: Is radiation therapy curative

903

Cancer of the Colon and Rectum in California: Trends in Incidence by Race/Ethnicity, Stage, and Subsite,

904

Cancer of the esophagus: histopathological sub-types in northern Uganda

905

Cancer of the gastric cardia

906

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation

907

Cancer of the larynx in females

908

Cancer of the larynx in Hong Kong: a clinico-pathological study

909

Cancer of the pharynx and larynx

910

Cancer of the rectum—palliative endoscopic treatment

911

Cancer of unknown primary origin: a decade of experience in a community-based hospital

912

Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?

913

Cancer omics: From regulatory networks to clinical outcomes

914

Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks

915

Cancer pain relief achieved in mice with proenkephalin-expressing herpes vector

916

Cancer pain relief, 2nd Edn : WHO, Geneva. £11.90, ISBN 92 4 154482 1

917

Cancer Pain; Physical Factors affecting Pain Experience

918

Cancer paper retracted

919

Cancer patient advocacy: New opportunities for treatment advances

920

Cancer patient survival in Estonia 1995–2009: Time trends and data quality

921

Cancer patients and loneliness: A systematic review

922

Cancer patients desire for information: a study in a teaching hospita l in Saudi Arabia

923

Cancer patients overestimate survival chances

924

Cancer patients' satisfaction with communication and information given by nurses at teaching hospitals of Tehran, Iran

925

Cancer patientsʹ satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results

926

Cancer Patients Who Elect Euthanasia as an Option: An Argumentative Essay

927

Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making i

928

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

929

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

930

Cancer patients’ reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: A preliminary study

931

Cancer pattern and survival in a rural district in South India

932

Cancer prevention

933

Cancer Prevention - Behavior Changes: The Short and the Long of It

934

Cancer prevention – the potential for diet to modulate molecular signalling

935

Cancer Prevention & Control Strategy: Resolution adopted by the 58th World Health Assembly, Geneva, May 25, 2005

936

Cancer Prevention Among Urban Southwestern American Indian Women: Comparison to Selected Year 2000 National Health Objectives

937

Cancer prevention by carotenoids

938

Cancer prevention by food factors through targeting signal transduction pathways,

939

Cancer Prevention by Protease Inhibitors

940

Cancer prevention by tocopherols and tea polyphenols

941

Cancer prevention in primary care: Predictors of patient counseling across four risk behaviors over 24 months

942

Cancer prevention in rural primary care: An academic-practice partnership

943

Cancer prevention studies: Past, present, and future directions

944

Cancer prevention studies—Past, present, and future directions

945

Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

946

Cancer Prevention: Chemoprevention vs Dietary Modifications

947

Cancer prevention: epidemiology and experiment

948

Cancer Prevention; Cancer Risk Management

949

Cancer Prevention; Emerging Infectious Diseases as Risk Factors, Iran Feature

950

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters Original Research Article

951

Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Original Research Article

952

Cancer preventive effects of flavonoids—a review

953

Cancer preventive potential of trichothecenes from Trichothecium roseum Original Research Article

954

Cancer preventive properties of ginger: A brief review

955

Cancer preventive screening: A cross-border comparison of United States and Canadian Chinese women

956

Cancer procoagulant and blood platelet activation

957

Cancer progression and p53

958

Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer

959

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

960

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

961

Cancer proteomics: from signaling networks to tumor markers

962

Cancer proteomics: from signaling networks to tumor markers

963

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

964

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

965

Cancer rectocolique chez le sujet jeune

966

Cancer rectocolique chez le sujet jeune

967

Cancer Registry in Iran: a Brief Overview

968

Cancer related factors do not explain the quality of life scores for childhood cancer survivors analysed with two different generic HRQL instruments

969

Cancer Related Fears in Iranian Patients, a Survey from South East of Iran

970

Cancer related inflammation: The macrophage connection

971

Cancer research priorities for early diagnosis in Iran: Analyses based on Multiple-Attribute Decision Making Model

972

Cancer Research Studies in Native Hawaiians and Pacific Islanders

973

Cancer Research UK looks to NCI forsuccess

974

Cancer researchers get down to arrays at AACR

975

Cancer Resection on the Residual Lung After Pneumonectomy for Bronchogenic Carcinoma

976

Cancer responds better to combined treatments

977

Cancer risk above 1 Gy and the impact for space radiation protection Original Research Article

978

Cancer risk after a hospital discharge diagnosis of endometriosis, , ,

979

Cancer risk after non-melanoma skin cancer

980

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

981

Cancer risk analysis by fuzzy logic approach and performance status of the model

982

Cancer Risk Analysis of Benzene and Ethyl Benzene in Painters

983

Cancer risk and all-cause mortality among Norwegian military United Nations peacekeepers deployed to Kosovo between 1999 and 2011

984

Cancer risk and Barrett’s esophagus

985

Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

986

Cancer Risk Assessment Benzene, Toluene, Ethylbenzene and Xylene (BTEX) in the Production of Insulation Bituminous

987

Cancer Risk Assessment due to Accidental Exposure inside Neutron Laboratories using BEIR VII Model

988

Cancer risk assessment for Tehran research reactor and radioisotope laboratory with CAP88-PC code (Gaussian plume model)

989

Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran

990

Cancer Risk Assessment From Multi-Exposure to Chloroform in Drinking Water of Ilam City, Iran

991

Cancer risk assessment from trihalomethanes in drinking water

992

Cancer Risk Assessment in Welder's Under Different Exposure Scenarios

993

Cancer risk assessment using blood dioxin levels and daily dietary TEQ intake in general populations of industrial and non-industrial countries

994

Cancer Risk Assessment: Evolution of the Process

995

Cancer Risk Assessment: Quality and Impact of the Family History Interview

996

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty

997

Cancer risk due to contamination: Consideration from market basket survey in Qatar

998

Cancer risk factors among men of diverse Hispanic or Latino origins

999

Cancer risk in endoscopically unresectable colon polyps

1000

Cancer risk in hypertensive patients treated with calcium channel blockers

بازگشت